体外膜氧合作为肺移植桥接:实践模式与患者结局
该研究基于美国器官共享联合网络2000至2019年数据,回顾性分析40,866例成人孤立肺移植患者,其中1,387例(3.4%)为体外膜氧合(ECMO)桥接组。结果显示,与2000-2004年相比,2015-2019年ECMO组和非ECMO组的死亡风险均显著降低,ECMO组调整风险比(aHR)为0.59(95%CI 0.37-0.96),非ECMO组为0.74(95%CI 0.70-0.79)。
要点
- 2000-2019年间,ECMO桥接肺移植患者占全部成人孤立肺移植的3.4%(1,387/40,866)。
- ECMO组和非ECMO组的平均年龄及初始肺分配评分在研究期间均显著上升,但ECMO组上升速度较慢。
- 与2000-2004年相比,2015-2019年ECMO组死亡风险aHR为0.59(95%CI 0.37-0.96),非ECMO组为0.74(95%CI 0.70-0.79)。
核心结论
- 尽管ECMO桥接患者的插管年龄逐渐增大且病情更重,但ECMO桥接肺移植患者的移植后生存率持续改善。
研究设计与样本
- 回顾性研究,基于美国器官共享联合网络(United Network for Organ Sharing)数据库2000至2019年间所有成人孤立肺移植患者,共40,866例,其中ECMO桥接组1,387例(3.4%),非ECMO组39,479例(96.6%)。
主要发现
- 研究期间ECMO组和非ECMO组的平均年龄及初始肺分配评分均显著增加,但ECMO组增加速度较慢。
- 与2000-2004年相比,2015-2019年ECMO组死亡风险显著降低,aHR为0.59(95%CI 0.37-0.96)。
- 与2000-2004年相比,2015-2019年非ECMO组死亡风险显著降低,aHR为0.74(95%CI 0.70-0.79)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is increasingly relied on to bridge patients with respiratory failure to lung transplantation despite limited evidence for its use in this setting. This study evaluated longitudinal trends in practice patterns, patient characteristics, and outcomes in patients bridged with ECMO to lung transplant. METHODS: A retrospective review of all adult isolated lung transplant patients in the United Network for Organ Sharing database between 2000 and 2019 was performed. Patients were classified as "ECMO" if supported with ECMO at the time of listing or transplantation and "non-ECMO" otherwise. Linear regression was used to evaluate trends in patient demographics during the study period. Trends in mortality were evaluated using Cox proportional hazards modeling, with time period as the primary covariate (2000-2004, 2005-2009, 2010-2014, or 2015-2019) and age, time on the waitlist, and underlying diagnosis as covariates. RESULTS: The number of patients included were 40,866, of whom 1,387 (3.4%) were classified as ECMO and 39,479 (96.6%) as no ECMO. Average age and initial Lung Allocation Score increased significantly during the study period in both cohorts, but occurred at a slower rate in the ECMO population. The hazard of death was significantly lower in more recent years (2015-2019) for both the ECMO and non-ECMO cohorts (aHR (adjusted hazards ratio) 0.59, 95% confidence interval (CI) 0.37-0.96 and aHR 0.74, 95% CI 0.70-0.79) when compared to the early years (2000-2004) of the study period. CONCLUSIONS: Post-transplantation survival for patients bridged to transplantation with ECMO demonstrates ongoing improvement despite cannulation of progressively older and sicker patients.
引用
- Rando HJ, Fanning JP, Cho SM, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation: Practice patterns and patient outcomes. J Heart Lung Transplant. 2023. PMID: 37394023. doi:10.1016/j.healun.2023.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。